PERSONALIZED THERAPY IN CARDIOLOGY: THE ROLE OF PHARMACOGENETICS AND BIOMARKERS IN THE SELECTION OF ANTIHYPERTENSIVE AND ANTIPLATELET AGENTS - POTENTIAL AND LIMITATIONS OF IMPLEMENTATION. Genetics and Molecular Research, [S. l.], 2026. DOI: 10.4238/z3e7ft80. Disponível em: https://geneticsmr.com/index.php/gmr/article/view/890.. Acesso em: 9 jun. 2026.